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Our laboratory has established that nurse-like cells
(NLCs) are present in the synovial tissues and bone
marrow of patients with rheumatoid arthritis (RA) [1–3].
Such cells, which were first discovered in thymus, play
an important role in thymocyte maturation and differenti-
ation [4–6]. In vitro, they form unique complexes with
thymocytes, which initially adhere to them and then
crawl beneath them [7–9]. This phenomenon, which is
unique to NLCs at various tissue sites, has been called
‘pseudoemperipolesis’. NLCs from RA synovial tissue
(RA-NLCs) promote survival of B cells [2,3] and main-
tain the growth of myeloid cells of patients with RA [1],
suggesting that they contribute profoundly to pathogen-
esis in RA.
Abstract
Bone resorption in the joints is the characteristic finding in patients with rheumatoid arthritis (RA).
Osteoclast-like cells are present in the synovial tissues and invade the bone of patients with RA. The
characteristics of these cells are not completely known. In the work reported here, we generated these
cells from peripheral-blood monocytes from healthy individuals. The monocytes were co-cultured with
nurse-like cells from synovial tissues of patients with RA (RA-NLCs). Within 5 weeks of culture, the
monocytes were activated and differentiated into mononuclear cells positive for CD14 and tartrate-
resistant acid phosphatase (TRAP). These mononuclear cells then differentiated into multinucleated
giant bone-resorbing cells after stimulation with IL-3, IL-5, IL-7, and/or granulocyte-macrophage-
colony-stimulating factor. TRAP-positive cells with similar characteristics were found in synovial fluid
from patients with RA. These results indicate that multinucleated giant bone-resorbing cells are
generated from monocytes in two steps: first, RA-NLCs induce monocytes to differentiate into TRAP-
positive mononuclear cells, which are then induced by cytokines to differentiate into multinucleated
giant bone-resorbing cells.
Keywords: monocytes, nurse cells, osteoclasts, rheumatoid arthritis, stromal cells
Received: 6 December 2000
Revisions requested: 9 February 2001
Revisions received: 12 June 2001
Accepted: 22 June 2001
Published: 2 August 2001
Arthritis Res 2001, 3:306–310
This article may contain supplementary data which can only be found
online at http://arthritis-research.com/content/3/5/306
© 2001 Toyosaki-Maeda et al, licensee BioMed Central Ltd
(Print ISSN 1465-9905; Online ISSN 1465-9913)
DMEM = Dulbecco’s modified Eagle’s medium; FCS = fetal calf serum; GM-CSF = granulocyte/macrophage-colony-stimulating factor; HLA =
human major histocompatibility antigen; IL = interleukin; NLC = nurse-like cell; RA = rheumatoid arthritis; RANKL = receptor activator of nuclear-
factor-κB ligand; RA-NLC = nurse-like cell derived from rheumatoid arthritis synovial tissue; TRAP = tartrate-resistant acid phosphatase.
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Multinucleated cells in synovial tissues have been reported
to invade the bone of patients with RA [10]. The cells’
expression of tartrate-resistant acid phosphatase (TRAP)
and calcitonin receptor suggested that they are osteo-
clasts [11,12]. Although the presence of osteoclast-like
cells in rheumatoid synovium is well understood, the
mechanism by which they differentiate is not. In order to
examine the effect of RA-NLCs on monocyte functions, we
co-cultured peripheral-blood monocytes with RA-NLCs
and looked for morphological and functional alterations of
CD14- and TRAP-positive cells. We also found such cells
in synovial fluid from patients with RA. These cells
differentiated into multinucleated giant bone-resorbing
cells in the presence of IL-3, IL-5, IL-7, and/or granulocyte/-
macrophage-colonystimulating factor (GM-CSF). In this
way we defined the process by which bone-resorbing
cells are generated from monocytic cells.
Materials and methods
Isolation of NLCs from RA synovial tissues
RA-NLCs were established from RA synovial tissues as
previously described [1]. Briefly, synovial tissues were
obtained from knee joints of five patients with RA who ful-
filled American College of Rheumatology criteria for RA
[13], after informed consent had been obtained. The cells
were cultured in DMEM (Dulbecco’s modified Eagle’s
medium [DMEM; Gibco BRL, Gaithersburg, MD, USA]
supplemented with 10% fetal calf serum [FCS; Hyclone,
Logan, UT, USA], 100 units/ml of penicillin [Gibco BRL],
and 100 µg/ml of streptomycin [Gibco BRL] at 37°C in
7.5% CO2. RA-NLCs were identified by their ability to
support pseudoemperipolesis, seen in vitro in the migra-
tion of a T-cell lymphoma line, MOLT-17, beneath the
NLCs, as previously described [3].
Isolation of mononuclear cells from RA synovial fluid
Synovial fluid was obtained from patients with RA who ful-
filled the American College of Rheumatology criteria for
RA [13]. The infiltrating cells were collected from the fluid
by centrifugation at 1900 g and were cultured in supple-
mented DMEM. After 3 to 5 weeks of culture, most of the
lymphocytes and granulocytes disappeared and mono-
cyte-like cells became dominant. CD14-positive mono-
cyte-like cells were purified from this population with a
magnetic-activated cell sorter (MACS; Myltenyi Biotec
GmbH, Germany) using anti-CD14 antibody conjugated
to magnetic beads in accordance with the manufacturer’s
instructions. The purity of CD14-positive cells was
analyzed using a fluorescence-activated cell sorter
(FACScan™; see Supplementary material).
Isolation and culture of monocytes from peripheral blood
Peripheral-blood monocytes were collected as plastic-
adherent cells, as described previously [14]. Mononuclear
cells were isolated from heparinized peripheral blood from
five healthy volunteers [15]. Over 97% of the adherent
cells were determined to be monocytes by morphology
and CD14 expression.
Monocytes (1 × 106) were co-cultured with RA-NLCs.
After 3 to 5 weeks, TRAP-positive mononuclear cells with
abundant cytoplasm became dominant. They were col-
lected by gently washing the culture with warm supple-
mented DMEM and their purity was confirmed
cytochemically.
Formation of multinucleated giant cells by
TRAP-positive mononuclear cells
The CD14-positive and TRAP-positive mononuclear cells
from the synovial fluid of patients with RA were examined
for expression of surface antigen and for phagocytic activ-
ity and were stimulated with various cytokines (see Sup-
plementary material).
TRAP-positive mononuclear cells (5 × 104) were cultured
in supplemented DMEM in the presence or absence of
various cytokines or in conditioned medium ([15]; and see
Supplementary material) for 96–120 h. In the presence of
receptor activator nuclear factor κB ligand (RANKL), cul-
tures were maintained for 14 days. At the end of the
culture period, May–Grunwald–Giemsa (Wako Pure
Chemical Co., Osaka, Japan) and TRAP staining (TRAP-
staining kit; Sigma, St Louis, MO, USA) were conducted.
The frequency of osteoclasts was evaluated from the
fusion index, as previously described [16]. More than
1000 nuclei within TRAP-positive multinucleated cells
(>4 nuclei/cell) were counted. The fusion index (%) was
calculated according to the formula:
total no. of nuclei within multinucleated cells × 100
total no. of nuclei counted
where ‘multinucleated cells’ are cells with >4 nuclei.
Examination of bone resorption
TRAP-positive mononuclear cells (5 × 104) were stimu-
lated with various cytokines on a dentin slice for 7 days. In
order to examine resorption areas with a scanning electron
microscope, the differentiated cells were washed off the
slices with distilled water. Then the slices were dehy-
drated, air-dried, and sputtered with gold.
Results
Morphological changes of peripheral-blood monocytes
after co-culture with RA-NLCs
After peripheral-blood monocytes had been cultured with
RA-NLCs for 3 to 4 weeks, we recovered TRAP-positive
mononuclear cells (Fig. 1a–1c) with abundant cytoplasm
and an off-center nucleus (Fig. 1a and 1b). These cells
strongly expressed CD11b, CD11c, CD14, CD45, and
human major histocompatibility antigen (HLA)-DR, sug-Arthritis Research    Vol 3 No 5 Toyosaki-Maeda et al
gesting that they were of monocyte lineage (Table 1).
However, they did not express CD11a, CD35, or CD68,
which are expressed on freshly isolated monocytes (see
Supplementary material).
Presence of TRAP-positive mononuclear cells in
synovial fluid from patients with RA
We detected monocytic cells positive for CD14 and
TRAP in synovial fluids of patients with RA. These cells
also strongly expressed CD11b, CD11c, CD14, CD45,
and HLA-DR (see Supplementary meterial) but not CD1a,
CD1b, CD2, CD5, or CD86, which are expressed on den-
dritic cells derived from monocytes [17]. These results
indicate that TRAP-positive monocytic cells present in
synovial fluid and those induced in vitro in cultures with
RA-NLCs are morphplogically and phenotypically the
same. These cells were obtained from the synovial fluid of
all patients with RA, regardless of age and sex. CD14-
positive monocyte-like cells accounted for 20–91% of the
mononuclear cells freshly isolated from the synovial fluid of
such patients (data not presented).
Differentiation of TRAP-positive mononuclear cells into
multinucleated giant bone-resorbing cells in the
absence of RA-NLCs
The TRAP-positive cells induced in vitro and those iso-
lated from synovial fluid both differentiated into multinucle-
ated cells after being cultured for 72 to 96 h with the
conditioned medium (Fig. 1d). These multinucleated cells
still possessed TRAP activity (data not shown) and formed
resorption areas on dentin slices (Fig. 2), suggesting that
they had bone-resorbing activity as osteoclasts.
Induction of multinucleated cells by IL-3, IL-5, IL-7 or
GM-CSF
The cytokines IL-3, IL-5, IL-7, and GM-CSF induced differ-
entiation of TRAP-positive cells induced in vitro or those
isolated from synovial fluid into osteoclasts (Table 1).
Regardless of which cytokine was used to stimulate differ-
entiation of the osteoclasts, they were all positive for
TRAP and formed resorption pits on dentin slices, sug-
gesting that they were all identical to the cells induced by
conditioned medium (data not shown). The fusion index of
osteoclasts induced by a mixture of cytokines was higher
than those stimulated with a single cytokine. The cytokines
IL-6 and IL-8, which are produced by RA-NLCs [2], did
not induce osteoclast formation. RANKL was recently
reported to induce osteoclasts from human peripheral
blood [18,19]; however, a mixture of macrophage-colony-
stimulating factor and RANKL exhibited only weak activity
for induction of osteoclasts from the TRAP-positive
mononuclear cells (Table 1). Phytohemagglutinin, which
was contained in the conditioned medium, did not induce
differentiation. TRAP-positive cells from the synovial fluid
of patients with RA have a fusion index similar to that
found for the TRAP-positive cells obtained experimentally
from monocytes (data not shown). Induction of the osteo-
clasts was completely neutralized by the antibody to each
cytokine (see Supplementary material).
Discussion
We have shown that the novel ability of RA-NLCs may
contribute to the pathogenesis of RA by encouraging the
generation of TRAP-positive mononuclear cells, which are
osteoclast precursors. The TRAP-positive precursor cells
have phagocytic activity and are negative for CD83, sug-
gesting that they are different from peripheral-blood mono-
cytes and dendritic cells [14,17].
Fujikawa et al reported that synovial macrophages differ-
entiated into osteoclasts after incubation in the presence
of a rat osteoblast-like cell line [20]. The fibroblasts
isolated from RA synovia induced differentiation of
monocytes into multinucleated cells in the presence 
of 1,25-dihydroxyvitamin D3 and macrophage-colony-
Figure 1
Morphology of TRAP-positive mononuclear cells induced from
peripheral-blood monocytes with RA-NLCs. (a) Phase-contrast
micrograph of monocytes co-cultured with RA-NLCs. Mononuclear
cells (arrow) are growing on the RA-NLCs. (b) Mononuclear cells
collected from the culture shown in (a). May–Grunwald–Giemsa
staining. (c) Detection of TRAP expressed by the mononuclear cells
(TRAP-positive cells were stained red with their cytoplasm). 
(d) Differentiated mononuclear cells. The cells shown here are
multinucleated giant cells. May–Grunwald–Giemsa staining. 
Scale lines = 100 µm.Available online http://arthritis-research.com/content/3/5/306
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stimulating factor [21]. Further study will be required to
determine the identity of those monocytic cells and our
cells. Fibroblastic cells in synovial fluid from patients with
RA have been reported to support pseudoemperipolesis,
which was considered to be the unique feature of the
nurse cells, in the presence of IL-4 [22]. Shigeyama et al
recently reported that RA synovial fluid may promote
osteoclastogenesis from monocytes by expressing osteo-
clast differentiation factor [23]. It is likely that RA fibrob-
lasts and RA-NLCs share several roles in the
pathogenesis of RA, including activation of monocytes.
However, the molecules required in our study for osteo-
clastogenesis from monocytes were different from those in
the study of Shigeyama et al [23]. These findings suggest
that multiple pathways for osteoclastogenesis in RA
synovia may cause severe joint destruction.
There may be two steps for generation of the osteoclasts
in the joints of patients with RA: first, differentiation of
monocytes into TRAP-positive mononuclear cells induced
and maintained by RA-NLCs, followed by cytokine-
induced differentiation of these mononuclear cells into
osteoclasts. The interaction between monocytes and RA-
NLCs required adhesion molecules, but RANK (receptor
activator of nuclear-factor-κB) and RANKL were not nec-
essary to induce the TRAP-positive cells in preliminary
studies in our laboratory (unpublished observation). The
molecules required in the interaction are under investiga-
tion. In addition, we found the presence of TRAP-positive
mononuclear cells which differentiated into osteoclasts in
synovial fluids of patients with RA in vitro. Monocytes may
infiltrate the affected joints and differentiate into TRAP-
positive mononuclear cells under the influence of RA-
NLCs. This conclusion is consistent with previous findings
of TRAP-positive multinucleated giant cells in the synovial
tissue of patients with RA [10–12]. Further studies are
required to characterize these osteoclasts derived from
the TRAP-positive mononuclear cells and to delineate the
unique course of differentiation into bone-resorbing cells
promoted by RA-NLCs.
Figure 2
Scanning electron micrographs of dentin slices, showing (a) resorption
areas formed on dentin by TRAP-positive multinucleated giant cells
derived from monocytes and stimulated with granulocyte-macrophage-
colony-stimulating factor for 96 h and (b) a control slice incubated with
the TRAP-positive mononuclear cells in the absence of cytokines.
Scale lines = 50 µm.
Table 1
Differentiation of human TRAP-positive mononuclear cells
derived from peripheral-blood monocytes into multinucleated
cells after stimulation with IL-3, IL-5, IL-7, and GM-CSF
Stimulator Concentration Fusion index (%) a
None 1.8
Conditioned mediumb (10% v/v) 86.1
IL-1α (1 ng/ml) 1.1
IL-1β (1 ng/ml) 1.3
IL-2 (250 U/ml) 7.7
IL-3 (5 ng/ml) 64.8
IL-4 (100 U/ml) 1.3
IL-5 (1 ng/ml) 66.1
IL-6 (20 ng/ml) 5.6
IL-6 + sIL-6R (sIL-6R: 200 ng/ml) 5.3
IL-7 (20 ng/ml) 72.4
IL-8 (20 ng/ml) 2.1
IFN-γ (100 U/ml) 7.1
GM-CSF (1 ng/ml) 73.8
M-CSF (25 ng/ml) 5.8
TNF-α (1 ng/ml) 6.9
VD3 (10–7 mol/l) 3.4
Dexamethasone (10–8 mol/l) 0.8
M-CSF + IL-4 (M-CSF, 25 ng/ml; IL-4,100 U/ml) 0.1
IL-3 + IL-7 75.4
IL-7 + GM-CSF 77.3
IL-3 + IL-7 + GM-CSF 78.7
Phytohemagglutinin (1% v/v) 2.0
RANKLc (100 ng/ml) 2.6
RANKL + M-CSF c (RANKL/ODF, 100 ng/ml;  38.1
M-CSF, 25 ng/ml)
aTRAP-positive mononuclear cells were stimulated with various cytokines
for 96–120 h. Fusion indices were calculated using the formula given in
the text and previously [16]. Data are representative of three independent
experiments using TRAP-positive cells induced from monocytes. bSee
[15], and Supplementary material. cThe culture was maintained for 14
days. GM-CSF = granulocyte macrophage-colony-stimulating factor; 
IFN = interferon; IL = interleukin; M-CSF = macrophage-colony-
stimulating factor; ODF = osteoclast differentiation factor; 
RANKL = receptor activator of nuclear-factor-κB ligand; 
sIL-6R = soluble interleukin-6 receptor; TNF = tumor necrosis factor;
VD3 = 1,25-dihydroxyvitamin D3.Arthritis Research    Vol 3 No 5 Toyosaki-Maeda et al
Conclusion
In order to elucidate the role of RA-NLCs, monocytes
were co-cultured with RA-NLCs. Monocytes differentiated
into TRAP-positive mononuclear cells, the precursor cells
of osteoclasts. Osteoclasts were generated from TRAP-
positive mononuclear cells in the presence of IL-3, IL-5,
IL-7, and GM-CSF. TRAP-positive cells were also present
in synovial fluids of patients with RA. RA-NLCs may play a
significant role in the activation of monocytes and long-
term maintenance of differentiated monocytes (osteoclast
precursors). The present study suggests that monocytes
may differentiate into osteoclast precursor cells in the
affected joints of patients with RA.
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Supplementary material
Supplementary materials and methods
Cell lines
Human lung fibroblasts CCD-19Lu were obtained from
American Type Culture Collection (Rockville, MD, USA).
Human T cell line MOLT-17 was a generous gift from Dr J
Minowada (Fujisaki Cell Center, Okayama, Japan). These
cell lines were cultured as recommended by the providers.
Examination of pseudoemperipolesis
Pseudoemperipolesis was measured as previously
described [3]. RA synovial stromal cells (3 × 104) were
incubated in supplemented DMEM in 24-well cultureAvailable online http://arthritis-research.com/content/3/5/306
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plates overnight. The next day, MOLT-17 cells (1 × 106)
were added to the RA-NLC culture. Stromal cells with
more than three MOLT-17 cells beneath them after 6 h of
incubation were considered NLCs.
Long-term maintenance of monocytes by RA-NLCs
Monocytes (2.5 × 105) were co-cultured with RA-NLCs or
CCD-19Lu with or without culture inserts (Becton Dickin-
son, Franklin Lakes, NJ, USA) in supplemented DMEM in
48-well culture plates at 37°C in 7.5% CO2 for up to
70 days. Half of the medium was changed once a week.
The TRAP-positive mononuclear cells were collected from
the culture, stained with trypan blue, and counted for via-
bility under a microscope.
Antibodies and staining of cells
The cell-surface antigens on freshly isolated monocytes
and TRAP-positive mononuclear cells were examined by
staining with monoclonal antibodies specific for CD1a,
CD4, CD5, CD11a, CD11b, CD11c, CD13, CD14,
CD15, CD16, CD19, CD20, CD34, CD45, CD45RA,
CD45RO, CD54, HLA-DR (Becton Dickinson), CD1b
(Nichirei, Tokyo, Japan), CD2, CD3 (Ortho Diagnostics,
Raritan, NJ, USA), CD35, CD68 (DAKO Japan, Kyoto,
Japan), CD51/61, CD83, HLA-A, B and C (Pharmingen,
San Diego, CA, USA), CD80, and CD86 (Ancell, Bayport,
MN, USA). Antigen-expression was analyzed with a
FACScan flow cytometer (Becton Dickinson). Multinucle-
ated giant bone-resorbing cells differentiated from TRAP-
positive mononuclear cells were fixed with cold acetone
and stained immunohistochemically with rabbit polyclonal
antibodies specific for actin (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), carbonic anhydrase II (Rock-
land, Gilbertsville, PA, USA), or vitronectin receptor
(Chemicon International, Inc., Temecula, CA, USA). TRAP
activity in TRAP-positive mononuclear cells and multinu-
cleated giant bone-resorbing cells was examined using a
TRAP-staining kit (Sigma, St Louis, MO, USA). Neutraliz-
ing antibodies to human IL-3, IL-5, IL-7, and GM-CSF
were purchased from Genzyme (Cambridge, MA, USA).
Cytokines and reagents
Conditioned media were prepared as previously reported
[15]. Briefly, a mixture of peripheral-blood mononuclear
cells from 10 healthy donors was stimulated with phyto-
hemagglutinin at 37°C for 72 h. Culture supernatant fluids
were collected, filtered, and used as conditioned media.
IL-1α was purchased from Immugenex (Los Angeles, CA).
IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, soluble IL-6 receptor (sIL-
6R), interferon gamma (IFN-γ), granulocyte/macrophage-
colony stimulating factor (GM-CSF), macrophage-colony
stimulating factor, and tumor necrosis factor (TNF)-α were
purchased from R&D Systems, Inc. (Minneapolis, MN,
USA). IL-7 and IL-8 were purchased from Genzyme. 1,25-
dihydroxyvitamin D3 and dexamethasone were purchased
from Wako Pure Chemical Co. (Osaka, Japan). Receptor
activator of nuclear-factor-κB ligand (RANKL) was
obtained from Peprotech (London, UK).
Assessment of phagocytic activity
Phagocytic activity of TRAP-positive mononuclear cells
was assessed from their ingestion of heat-killed yeast.
TRAP-positive mononuclear cells (1 × 106) were incu-
bated with 2 × 107 yeast cells in phosphate-buffered
saline supplemented with 10% fresh human serum, type
AB, at 37°C for 45 min. The cells were washed and
stained with fuchsin (Wako Pure Chemical Co.), and the
cells with ingested yeast were counted under a micro-
scope.
Inhibition of the generation of multinucleated giant
cells from TRAP-positive mononuclear cells by
neutralizing antibodies
Neutralizing antibodies specific for IL-3, IL-5, IL-7, and GM-
CSF were used for inhibition of the generation of multinucle-
ated giant bone-resorbing cells. Irrelevant polyclonal mouse
IgG from Jackson ImmunoResearch (West Grove, PA,
USA) was used as a control. The TRAP-positive mononu-
clear cells (5 × 104) were pre-incubated with each antibody
in DMEM containing 10% FCS in microtubes at 37°C for
1 h. The cells were cultured in 4-well chamber slides, and
stimulated with a cytokine for 96–120 h at 37°C in 7.5%
CO2. At the end of the culture period, the cells were stained
for TRAP and the fusion index was calculated as described
in the main paper.
Detection of calcitonin receptors
Calcitonin receptors on the multinucleated giant bone-
resorbing cells were detected in situ using 125I-human cal-
citonin were performed as described elsewhere [23].
TRAP-positive mononuclear cells (5 × 104) were stimu-
lated with IL-3, IL-5, IL-7, or GM-CSF at the optimal con-
centrations in 4-well chamber slides (Nalge Nunc
International, Rochester, NY, USA) for 96–120 h at 37°C
in 7.5% CO2. After formation of multinucleated giant
bone-resorbing cells had been confirmed microscopically,
the cells were incubated in 0.4 ml αMEM (Gibco BRL)
with 0.1% bovine serum albumin and 0.2 mCi/ml of 125I-
labeled human calcitonin (Amersham Pharmacia Biotech,
Buckinghamshire, UK) for 1 h at 22°C. Nonspecific
binding was assessed on each slide in the presence of an
excess amount of unlabeled human calcitonin. Then the
cells were washed three times with phosphate-buffered
saline solution and fixed with 2.5% formaldehyde and
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer.
The slides were washed and dried as previously described
[S1]. Air-dried slides were dipped in photographic emul-
sion (Kodak NTB3; Eastman Kodak, Rochester, NY, USA),
drained, and dried for 2 h and were kept in a light-proof
container with desiccant at 4°C for 10 days. The slides
were developed in accordance with the manufacturer’s
instructions.Supplementary results
Phenotypic characterization of the TRAP-positive
mononuclear cells induced by NLCs
The TRAP-positive mononuclear cells, whether induced
from monocytes or collected from the synovial fluid of
patients with RA, strongly expressed CD11b, CD11c,
CD14, CD45, HLA-A, HLA-B, HLA-C, and HLA-DR but
did not express CD1a, CD1b, CD2, CD4, CD5, CD16,
CD19, CD20, or CD83. These observations suggest that
these cells belong to the monocyte/macrophage lineage
(Supplementary Table 1). However, the cells did not
express CD11a, CD35, or CD68, which are expressed on
freshly isolated monocytes from peripheral blood (Supple-
mentary Table 2). The TRAP-positive mononuclear cells
had strong phagocytic activity against heat-killed yeast
(data not presented). In addition, the cells were positive
for carbonic anhydrase II, actin, and vitronectin receptor
(Supplementary Fig. 1), and calcitonin receptors were also
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Supplementary Table 1
Expression of surface antigen by TRAP-positive mononuclear cells generated by co-culture with RA-NLC
% Positivea
Monocytes from  TRAP-positive cells induced  TRAP-positive cells 
Antigen peripheral blood from monocytes from RA-SF
CD1a 1.24 0.11 0.24
CD1b 0.22 0.13 0.12
CD2 2.20 0.18 1.01
CD3 0.82 0.85 0.82
CD4 0.28 0.61 0.35
CD5 0.23 0.44 0.29
CD11a LFA-1 94.72 1.16 1.18
CD11b CR3 α chain 95.46 99.42 99.56
CD11c CR4 α chain 99.47 99.22 99.01
CD13 99.44 96.15 93.87
CD14 95.70 99.28 99.63
CD15 Lex 22.81 0.49 15.97
CD16 FcgR III 0.72 0.24 0.30
CD19 0.33 0.13 0.13
CD20 0.36 0.11 0.10
CD34 0.54 0.18 0.18
CD35 CR1 93.49 0.50 0.60
CD45 98.73 94.28 92.90
CD45RA 0.37 0.15 0.46
RA45RO 0.65 4.18 3.30
CD51/61 VNRb 0.22 0.10 0.17
CD54 ICAM-1 0.21 0.30 0.33
CD68 94.59 1.06 1.10
CD80 B7/BB1 8.19 7.41 6.52
CD83 0.37 0.10 1.42
CD86 B70/FUN-1 90.01 0.55 1.21
HLA-A, -B, -C 97.44 99.68 99.53
HLA-DR 96.65 98.45 98.16
aCells were stained with monoclonal antibody specific for various antigens, and analyzed by FACScan. Data are representative of four independent
analyses. bVitronectin receptor. RA-SF = synovial fluid from patients with rheumatoid arthritis.detected (Supplementary Fig. 1); these four receptors are
considered characteristic of osteoclasts [10,23].
Long-term maintenance of monocytes by RA-NLCs
Monocytes obtained from all five healthy individuals and
co-cultured with RA-NLCs grew and differentiated into
TRAP-positive mononuclear cells (Supplementary Fig. 2).
We also used five RA-NLC lines, each from a different
patient with RA. All five cell lines induced the generation
of TRAP-positive mononuclear cells from human periph-
eral blood monocytes (data not presented). The genera-
tion of these TRAP-positive cells required direct contact
with RA-NLCs.
Induction of osteoclasts by IL-3, IL-5, IL-7, or GM-CSF
The conditioned medium contains several cytokines. In
order to determine which cytokines induce TRAP-positive
mononuclear cells to differentiate into multinucleated giant
bone-resorbing cells, in vitro induced TRAP-positive cells
and those isolated from synovial fluid of patients with RA
were collected and stimulated with various cytokines in
the absence of RA-NLCs. In a preliminary study, a high-
performance liquid chromatography fraction of the condi-
tioned medium, which was used to induce TRAP-positive
mononuclear cells to differentiate into multinucleated giant
bone-resorbing cells, contained proteins with a molecular
weight of approximately 20 kDa (data not shown). There-
fore, we mainly examined cytokines with approximately
that molecular weight. The activities of IL-3, IL-5, IL-7, and
GM-CSF for inducing multinucleated giant bone-resorbing
cells were completely neutralized by the antibody to the
respective cytokine (Supplementary Table 2).
Supplementary reference
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Supplementary Figure 1
Immunohistochemical staining of multinucleated giant bone-resorbing
cells. The cells were stained green for (a) carbonic anhydrase II and
(b) vitronectin receptor. The cells were also positive for (c) actin,
which showed red, ring-form staining. (d) In situ detection of calcitonin
receptor using 125I-human calcitonin. Black grains mark the cells
expressing calcitonin receptor. The multinucleated giant bone-
resorbing cells were incubated with 125I-human calcitonin for 1 h. The
cells were washed, fixed, and dried as described in the Supplementary
materials and methods section. Air-dried slides were exposed at 4°C
for 10 days. Scale lines = 100 µm.
Supplementary Table 2
Inhibition of formation of multinucleated giant cells by neutralizing antibodies specific for IL-3, IL-5, IL-7, and GM-CSF
Fusion index (%) a
Antibodyb IL-3 (5 ng/ml) IL-5 (1 ng/ml) IL-7 (20 ng/ml) GM-CSF (1 ng/ml)
Polyclonal mouse IgG 63.8 ± 1.2 62.3 ± 3.6 66.2 ± 5.4 67.7 ± 6.0
Anti-IL-3 7.3 ± 1.6  – – –
Anti-IL-5 – 3.8 ± 1.8 – –
Anti-IL-7 – – 5.5 ± 5.8 –
Anti-GM-CSF – – – 4.0 ± 1.3
aFusion indices were calculated using the formula given in the Methods section. Each value is the mean ± SD of three independent experiments
using TRAP-positive cells induced from monocytes of three individuals. bConcentrations of cytokines: polyclonal mouse IgG, 10 mg/ml; anti-IL-3,
10 mg/ml; anti-IL-5, 5 mg/ml; anti-IL-7, 10 mg/ml, anti-GM-CSF, 2 mg/ml.  – = not examined; GM-CSF = granulocyte/macrophage-colony-
stimulating factor; IL = interleukin.Arthritis Research    Vol 3 No 5 Toyosaki-Maeda et al
Supplementary Figure 2
Effects of culture conditions on survival of monocytes from five donors with RA-NLCs or CCD-19Lu, in the presence (separated) or absence (no
indication) of culture inserts. Each culture was maintained for up to 70 days. The resulting mononuclear cells were collected, stained with trypan
blue, and counted under a microscope. Each experiment was conducted in duplicate, and each point represents the mean number of viable cells in
two cultures.